These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3106047)
1. Very low density lipoprotein metabolism after insulin over-treatment and during a euglycaemic clamp. Kruszynska YT; Home PD; Alberti KG Eur J Clin Invest; 1987 Feb; 17(1):23-8. PubMed ID: 3106047 [TBL] [Abstract][Full Text] [Related]
2. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Yki-Järvinen H; Taskinen MR; Koivisto VA; Nikkilä EA Diabetologia; 1984 Sep; 27(3):364-9. PubMed ID: 6389242 [TBL] [Abstract][Full Text] [Related]
3. Lipid metabolism and insulin resistance in cirrhosis. Kaye GL; Kruszynska YT; Harry DS; Heslop K; Johnston DG; McIntyre N J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479 [TBL] [Abstract][Full Text] [Related]
4. Correction by insulin of disturbed TG-rich LP metabolism in rats with chronic renal failure. Roullet JB; Lacour B; Yvert JP; Drueke T Am J Physiol; 1986 Apr; 250(4 Pt 1):E373-6. PubMed ID: 3515962 [TBL] [Abstract][Full Text] [Related]
5. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome. Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367 [TBL] [Abstract][Full Text] [Related]
6. Effects of non-esterified fatty acid availability on insulin stimulated glucose utilisation and tissue pyruvate dehydrogenase activity in the rat. Kruszynska YT; McCormack JG; McIntyre N Diabetologia; 1990 Jul; 33(7):396-402. PubMed ID: 2119322 [TBL] [Abstract][Full Text] [Related]
7. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats. Koopmans SJ; Kushwaha RS; DeFronzo RA Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109 [TBL] [Abstract][Full Text] [Related]
8. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1. Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474 [TBL] [Abstract][Full Text] [Related]
10. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381 [TBL] [Abstract][Full Text] [Related]
11. Effects of glycogen stores and non-esterified fatty acid availability on insulin-stimulated glucose metabolism and tissue pyruvate dehydrogenase activity in the rat. Kruszynska YT; McCormack JG; McIntyre N Diabetologia; 1991 Apr; 34(4):205-11. PubMed ID: 2065855 [TBL] [Abstract][Full Text] [Related]
12. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone. Kazumi T; Hirano T; Odaka H; Ebara T; Amano N; Hozumi T; Ishida Y; Yoshino G Diabetes; 1996 Jun; 45(6):806-11. PubMed ID: 8635657 [TBL] [Abstract][Full Text] [Related]
13. Alterations of lipid and cholesterol metabolism in cachectic tumor-bearing rats are prevented by insulin. Costelli P; Tessitore L; Batetta B; Mulas MF; Spano O; Pani P; Baccino FM; Dessì S J Nutr; 1999 Mar; 129(3):700-6. PubMed ID: 10082777 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein lipase in rats fed fish oil: apparent relationship to plasma insulin levels. Baltzell JK; Wooten JT; Otto DA Lipids; 1991 Apr; 26(4):289-94. PubMed ID: 1865765 [TBL] [Abstract][Full Text] [Related]
16. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria. Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350 [TBL] [Abstract][Full Text] [Related]
17. Modulation of lipoprotein lipase activity in the rat by the beta 2-adrenergic agonist clenbuterol. Belahsen R; Deshaies Y Can J Physiol Pharmacol; 1992 Dec; 70(12):1555-62. PubMed ID: 1363787 [TBL] [Abstract][Full Text] [Related]
18. Factors of increase in serum triglyceride-rich lipoproteins in uremic rats. Roullet JB; Lacour B; Yvert JP; Prat JJ; Drueke T Kidney Int; 1985 Feb; 27(2):420-5. PubMed ID: 3886997 [TBL] [Abstract][Full Text] [Related]
19. Pathogenetic mechanisms of the endogenous hypertriglyceridemia in a nonobese rat model. Zavaroni I; Dall'Aglio E; Lovati MR; Alpi O; Bobbioni E; Allievi L; Butturini U; Sirtori CR Metabolism; 1986 May; 35(5):383-6. PubMed ID: 3517553 [TBL] [Abstract][Full Text] [Related]
20. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model. Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]